Skip to main content

Lafayette Investments, Inc.

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1308377 ASHTON, MD

Position in LCTX

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$20,540
-$1,170 QoQ
Shares Held
13,000
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Lafayette Investments, Inc. holds $37,429 across 2 Biotechnology names. LCTX ranks #1 (54.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LCTX
Lineage Cell Therapeutics, Inc.
This page
13,000 $20,540

All Filings in LCTX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,540 13,000
2025-12-31 $21,710 13,000
2025-09-30 $21,970 13,000
2025-06-30 $11,830 13,000
2025-03-31 $5,850 13,000
2024-12-31 $6,500 13,000
2024-09-30 $11,830 13,000
2024-06-30 $13,000 13,000
2024-03-31 $19,240 13,000
2023-12-31 $14,170 13,000
2023-09-30 $15,340 13,000
2023-06-30 $18,330 13,000
2023-03-31 $19,500 13,000
2022-12-31 $15,210 13,000
2022-09-30 $14,690 13,000
2022-06-30 $20,540 13,000
2022-03-31 $20,020 13,000
2021-12-31 $31,850 13,000
2021-09-30 $32,760 13,000
2021-06-30 $37,050 13,000
2021-03-31 $30,550 13,000
2020-12-31 $17,600 10,000